Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Spruce Biosciences (SPRB) Return on Equity (2022 - 2025)

Spruce Biosciences (SPRB) has disclosed Return on Equity for 4 consecutive years, with 1.48% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Equity fell 16.0% to 1.48% in Q4 2025 year-over-year; TTM through Dec 2025 was 1.48%, a 16.0% decrease, with the full-year FY2025 number at 0.99%, up 1.0% from a year prior.
  • Return on Equity was 1.48% for Q4 2025 at Spruce Biosciences, up from 5.16% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.47% in Q2 2023 to a low of 5.16% in Q3 2025.
  • A 4-year average of 1.44% and a median of 0.69% in 2024 define the central range for Return on Equity.
  • Peak YoY movement for Return on Equity: grew 4bps in 2023, then plummeted -445bps in 2025.
  • Spruce Biosciences' Return on Equity stood at 0.63% in 2022, then increased by 6bps to 0.59% in 2023, then crashed by -123bps to 1.32% in 2024, then decreased by -12bps to 1.48% in 2025.
  • Per Business Quant, the three most recent readings for SPRB's Return on Equity are 1.48% (Q4 2025), 5.16% (Q3 2025), and 3.39% (Q2 2025).